Back to Search
KIRK WELLER, M.D.
M.D.
Neurology Physician
NPI: 1235169566Individual
Specialties, Licenses & Credentials
Research & Publications (19)
Biophysical and biological studies of end-group-modified derivatives of Pep-1.
PMID 16313183·Biochemistry·2005
8-other
Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo.
PMID 18769454·J Invest Dermatol·2009
3-trial
Desloratadine inhibits human skin mast cell activation and histamine release.
PMID 19516262·J Invest Dermatol·2009
8-other
Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.
PMID 18587651·AAPS J·2008
8-other
Influence of visual masking technique on the assessment of 2 red wines by trained and consumer assessors.
PMID 19241572·J Food Sci·2008
8-other
Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research.
PMID 17956214·Crit Rev Ther Drug Carrier Syst·2007
6-review
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent.
PMID 17525259·Am J Pathol·2007
7-preclinical
Acquired cold urticaria: clinical picture and update on diagnosis and treatment.
PMID 17355280·Clin Exp Dermatol·2007
6-review
Effects of structural modification on gene transfection and self-assembling properties of amphiphilic dendrimers.
PMID 16493456·Org Biomol Chem·2006
8-other
Mast cells are required for normal healing of skin wounds in mice.
PMID 16966487·FASEB J·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 24900 SE Stark St, Suite 211
Gresham, OR 97030 - Phone
- (503) 699-0435
Quick Facts
- NPI
- 1235169566
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Publications
- 19
Are you this provider?
Claim Your Profile